DSIP 10mg

R590,00

DSIP 10mg

Enhanced Deep Sleep, Cognitive Benefits, Mood Enhancement, Longevity

R590,00

48 in stock

What It Is?

DSIP (Delta Sleep-Inducing Peptide, is a lab-made synthetic nonapeptide – a chain of just 9 amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit cerebral venous blood in 1977. Discovered by Swiss researchers Schoenenberger and Monnier, it is naturally produced in the hypothalamus and has been studied for over 45 years primarily for its ability to promote deep, restorative (delta-wave) sleep without the hangover or dependence of traditional sleep meds.

Think of DSIP as your brain’s ‘deep-sleep optimizer.’ It gently nudges your sleep architecture toward more restorative slow-wave (delta) sleep rather than knocking you out like a sedative.

How it works

– Influences GABA-A receptors (calming brain activity) and the HPA axis (lowers cortisol/ACTH stress response).
– May boost growth hormone release during sleep and provide mild analgesic/neuroprotective effects.
– Normalizes disrupted sleep patterns without suppressing natural REM or altering overall sleep stages dramatically.

– Deeper, more efficient sleep: shorter sleep latency, higher sleep efficiency, increased delta waves, and feeling more refreshed.

– Stress & cortisol reduction: helps with chronic stress, withdrawal symptoms (alcohol/opioids), and HPA-axis balance.

– Pain relief & recovery support: mild analgesic effects; may aid muscle repair via better GH during sleep.

– Bonus signals: possible mood stabilization, neuroprotective hints in stroke models, and improved performance/alertness the next day.

In short: It enhances the quality of your natural sleep rather than forcing it – great for insomnia or high-stress recovery, but results vary and are not dramatic for everyone.

DSIP has one of the mildest safety profiles among researched peptides – decades of studies describe it as ‘incredibly safe’ with no lethal dose found in animals.

In human trials and reviews: Extremely well-tolerated; no serious adverse events.

Mild/rare effects:

– Transient headache, nausea, vertigo, or flushing (usually with first doses).
– Injection-site irritation.
– Unknown ultra-long-term effects – most studies are short (days to weeks).
– Bottom line: Far gentler than prescription sleep aids – side effects are rare and short-lived for most.

No official guidelines (investigational only), so these come from clinical protocols and clinic/research summaries.

Typical dose (subcutaneous injection, belly or thigh, 30-60 minutes before bed):

Reconstitute 2ml Bac water into10mg vial. See Reconsitution Guide

– 500 mcg per injection. Therefore, 10 units or 0.1ml. Vial should last 20 doses.
– Once daily at night; some use every other night or as needed for poor sleep nights.

Cycling:

– 4-8 weeks on, then 2-4 weeks off (to prevent any potential tolerance, though not strongly documented).
– Short courses (1-2 weeks) often suffice for acute stress or jet lag; many use it intermittently rather than long-term.

Tip: Reconstitute with bacteriostatic water; store in fridge. Use insulin syringes and sterile technique.

Human data is limited and mostly older (1980s-1990s); modern reviews note weak or inconsistent clinical significance. Here are the key ones:
1. Innerbody Research (updated Jan 2026): Full 2026 rundown – sleep quality, stress benefits, dosing (100-400mcg mcg), and ‘incredibly safe’ profile per editorial.
2. Bes et al. (1992) double-blind study (n=16 insomniacs): Higher sleep efficiency, shorter latency with DSIP vs placebo; weak but statistically significant objective improvements.
3. Pollard & Pomfrett (2001) editorial: DSIP described as ‘incredibly safe’ no animal lethality, minimal human side effects; promotes next-night sleep even if dosed daytime.
4. Graf (1984) comprehensive review: Classic overview – delta-wave induction in animals/humans, multifaceted effects (sleep, stress, hormones).
5. Tukhovskaya et al. (2021): DSIP improved motor recovery in rat stroke model (nasal administration); neuroprotective signals.
6. Anderer & Saletu (1991, referenced 2026): Reduced sleep latency by ~22 minutes in insomniacs.
7. DrLewis (Jan 2026 review): Balanced psychiatrist summary – mixed/conflicting research, weak clinical trials, but some sleep benefits noted.
8. Swolverine (2025–2026): Benefits for slow-wave sleep, GH release, recovery; dosing and mild risks overview.
9. Optimal Circadian Health (2026 guide): Comprehensive benefits, 100–400 mcg dosing, well-tolerated profile.
10. Exploring Peptides (Nov 2025): Mechanisms, benefits (sleep/stress/pain), research-use dosing (100-400 mcg).
Takeaway: Promising early data for deep sleep and stress, but larger modern RCTs are lacking — effects are often described as subtle or inconsistent.

Important disclaimer upfront: DSIP is NOT approved by the FDA (or any major agency) as of 2026. Its listed on the FDA’s Category 2 bulk substances list due to potential immunogenicity risks and insufficient safety data for compounding. It remains strictly investigational/research chemical. Long-term safety in healthy people is unknown. It is banned by WADA. Always talk to a doctor – this is not medical advice. Quality sourcing is critical.
img_1236

Energy, Focus, Mood Boost, Mental Clarity, Reduced Fatigue, Addiction Recovery, Anti- Aging, Neuroprotection, Reduced Inflammation.

R1 650,00

Add to cart
img_1159-2

Neurological Improvement, Enhanced Motor Function, Regained Independence, Consciousness, Cognitive Function, Neuroprotection

R450,00

Add to cart
img_1246

Anxiety Relief, Cognitive Enhancement, Focus, Memory, Learning, and Mental Clarity, Mood stabilization, Sleep Support

R550,00

Add to cart
img_1240

Rapid Antidepressant Effects, Cognitive Enhancement & Memory Support, Neuroprotection, Anti-Anxiety

R480,00

Read more
img_1239

The ‘Love Peptide’, Social Bonding, Trust, Emotional Connection, Anxiety Reduction, Mild Pain Modulation.

R450,00

Add to cart
img_1200

Neuropathic Pain Relief, Anti-inflammatory effects, Tissue protection, Healing, Fatigue, Quality of Life.

R550,00

Add to cart
0